化学療法誘発性貧血（CIA）の世界市場（～2026年）

• 英文タイトル：Global Chemotherapy Induced Anemia Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY11344
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は化学療法誘発性貧血（CIA）のグローバル市場について調査・分析したレポートです。種類別（軽度貧血、中等度貧血、重度貧血、生命にかかわる貧血）市場規模、用途別（病院、外来手術センター、専門クリニック、がん研究センター、がんリハビリセンター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別化学療法誘発性貧血（CIA）の競争状況、市場シェア
・世界の化学療法誘発性貧血（CIA）市場：種類別市場規模 2015年-2020年（軽度貧血、中等度貧血、重度貧血、生命にかかわる貧血）
・世界の化学療法誘発性貧血（CIA）市場：種類別市場規模予測 2021年-2026年（軽度貧血、中等度貧血、重度貧血、生命にかかわる貧血）
・世界の化学療法誘発性貧血（CIA）市場：用途別市場規模 2015年-2020年（病院、外来手術センター、専門クリニック、がん研究センター、がんリハビリセンター）
・世界の化学療法誘発性貧血（CIA）市場：用途別市場規模予測 2021年-2026年（病院、外来手術センター、専門クリニック、がん研究センター、がんリハビリセンター）
・北米の化学療法誘発性貧血（CIA）市場分析：米国、カナダ
・ヨーロッパの化学療法誘発性貧血（CIA）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの化学療法誘発性貧血（CIA）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の化学療法誘発性貧血（CIA）市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの化学療法誘発性貧血（CIA）市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Dr. Reddy’s Laboratories、Pfizer、Panacea Biotec、3SBio、SBI Pharmaceuticals、Tolero Pharmaceuticals、Vifor Pharma、Therapure Biopharma
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Anaemia is a frequent complication of malignancy and is aggravated by chemotherapy.
The key factor contributing to the growth of the global chemotherapy induced anemia market is the increase in the occurrence of cancer and anemia among geriatric patients.

Market Analysis and Insights: Global Chemotherapy Induced Anemia Market
The global Chemotherapy Induced Anemia market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Chemotherapy Induced Anemia Scope and Market Size
Chemotherapy Induced Anemia market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chemotherapy Induced Anemia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Dr. Reddy’s Laboratories
Pfizer
Panacea Biotec
3SBio
SBI Pharmaceuticals
Tolero Pharmaceuticals
Vifor Pharma
Therapure Biopharma

Market segment by Type, the product can be split into
Mild Anemia
Moderate Anemia
Severe Anemia
Life-Threatening Anemia
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Multispecialty Clinics
Cancer Research Centers
Cancer Rehabilitation Centers

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Chemotherapy Induced Anemia Revenue
1.4 Market by Type
1.4.1 Global Chemotherapy Induced Anemia Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Mild Anemia
1.4.3 Moderate Anemia
1.4.4 Severe Anemia
1.4.5 Life-Threatening Anemia
1.5 Market by Application
1.5.1 Global Chemotherapy Induced Anemia Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Multispecialty Clinics
1.5.5 Cancer Research Centers
1.5.6 Cancer Rehabilitation Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Chemotherapy Induced Anemia Market Perspective (2015-2026)
2.2 Global Chemotherapy Induced Anemia Growth Trends by Regions
2.2.1 Chemotherapy Induced Anemia Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Chemotherapy Induced Anemia Historic Market Share by Regions (2015-2020)
2.2.3 Chemotherapy Induced Anemia Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Chemotherapy Induced Anemia Market Growth Strategy
2.3.6 Primary Interviews with Key Chemotherapy Induced Anemia Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Chemotherapy Induced Anemia Players by Market Size
3.1.1 Global Top Chemotherapy Induced Anemia Players by Revenue (2015-2020)
3.1.2 Global Chemotherapy Induced Anemia Revenue Market Share by Players (2015-2020)
3.1.3 Global Chemotherapy Induced Anemia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Chemotherapy Induced Anemia Market Concentration Ratio
3.2.1 Global Chemotherapy Induced Anemia Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Chemotherapy Induced Anemia Revenue in 2019
3.3 Chemotherapy Induced Anemia Key Players Head office and Area Served
3.4 Key Players Chemotherapy Induced Anemia Product Solution and Service
3.5 Date of Enter into Chemotherapy Induced Anemia Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Chemotherapy Induced Anemia Historic Market Size by Type (2015-2020)
4.2 Global Chemotherapy Induced Anemia Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Chemotherapy Induced Anemia Market Size by Application (2015-2020)
5.2 Global Chemotherapy Induced Anemia Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Chemotherapy Induced Anemia Market Size (2015-2020)
6.2 Chemotherapy Induced Anemia Key Players in North America (2019-2020)
6.3 North America Chemotherapy Induced Anemia Market Size by Type (2015-2020)
6.4 North America Chemotherapy Induced Anemia Market Size by Application (2015-2020)

7 Europe
7.1 Europe Chemotherapy Induced Anemia Market Size (2015-2020)
7.2 Chemotherapy Induced Anemia Key Players in Europe (2019-2020)
7.3 Europe Chemotherapy Induced Anemia Market Size by Type (2015-2020)
7.4 Europe Chemotherapy Induced Anemia Market Size by Application (2015-2020)

8 China
8.1 China Chemotherapy Induced Anemia Market Size (2015-2020)
8.2 Chemotherapy Induced Anemia Key Players in China (2019-2020)
8.3 China Chemotherapy Induced Anemia Market Size by Type (2015-2020)
8.4 China Chemotherapy Induced Anemia Market Size by Application (2015-2020)

9 Japan
9.1 Japan Chemotherapy Induced Anemia Market Size (2015-2020)
9.2 Chemotherapy Induced Anemia Key Players in Japan (2019-2020)
9.3 Japan Chemotherapy Induced Anemia Market Size by Type (2015-2020)
9.4 Japan Chemotherapy Induced Anemia Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Chemotherapy Induced Anemia Market Size (2015-2020)
10.2 Chemotherapy Induced Anemia Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Chemotherapy Induced Anemia Market Size by Type (2015-2020)
10.4 Southeast Asia Chemotherapy Induced Anemia Market Size by Application (2015-2020)

11 India
11.1 India Chemotherapy Induced Anemia Market Size (2015-2020)
11.2 Chemotherapy Induced Anemia Key Players in India (2019-2020)
11.3 India Chemotherapy Induced Anemia Market Size by Type (2015-2020)
11.4 India Chemotherapy Induced Anemia Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Chemotherapy Induced Anemia Market Size (2015-2020)
12.2 Chemotherapy Induced Anemia Key Players in Central & South America (2019-2020)
12.3 Central & South America Chemotherapy Induced Anemia Market Size by Type (2015-2020)
12.4 Central & South America Chemotherapy Induced Anemia Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Dr. Reddy’s Laboratories
13.1.1 Dr. Reddy’s Laboratories Company Details
13.1.2 Dr. Reddy’s Laboratories Business Overview
13.1.3 Dr. Reddy’s Laboratories Chemotherapy Induced Anemia Introduction
13.1.4 Dr. Reddy’s Laboratories Revenue in Chemotherapy Induced Anemia Business (2015-2020))
13.1.5 Dr. Reddy’s Laboratories Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Chemotherapy Induced Anemia Introduction
13.2.4 Pfizer Revenue in Chemotherapy Induced Anemia Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Panacea Biotec
13.3.1 Panacea Biotec Company Details
13.3.2 Panacea Biotec Business Overview
13.3.3 Panacea Biotec Chemotherapy Induced Anemia Introduction
13.3.4 Panacea Biotec Revenue in Chemotherapy Induced Anemia Business (2015-2020)
13.3.5 Panacea Biotec Recent Development
13.4 3SBio
13.4.1 3SBio Company Details
13.4.2 3SBio Business Overview
13.4.3 3SBio Chemotherapy Induced Anemia Introduction
13.4.4 3SBio Revenue in Chemotherapy Induced Anemia Business (2015-2020)
13.4.5 3SBio Recent Development
13.5 SBI Pharmaceuticals
13.5.1 SBI Pharmaceuticals Company Details
13.5.2 SBI Pharmaceuticals Business Overview
13.5.3 SBI Pharmaceuticals Chemotherapy Induced Anemia Introduction
13.5.4 SBI Pharmaceuticals Revenue in Chemotherapy Induced Anemia Business (2015-2020)
13.5.5 SBI Pharmaceuticals Recent Development
13.6 Tolero Pharmaceuticals
13.6.1 Tolero Pharmaceuticals Company Details
13.6.2 Tolero Pharmaceuticals Business Overview
13.6.3 Tolero Pharmaceuticals Chemotherapy Induced Anemia Introduction
13.6.4 Tolero Pharmaceuticals Revenue in Chemotherapy Induced Anemia Business (2015-2020)
13.6.5 Tolero Pharmaceuticals Recent Development
13.7 Vifor Pharma
13.7.1 Vifor Pharma Company Details
13.7.2 Vifor Pharma Business Overview
13.7.3 Vifor Pharma Chemotherapy Induced Anemia Introduction
13.7.4 Vifor Pharma Revenue in Chemotherapy Induced Anemia Business (2015-2020)
13.7.5 Vifor Pharma Recent Development
13.8 Therapure Biopharma
13.8.1 Therapure Biopharma Company Details
13.8.2 Therapure Biopharma Business Overview
13.8.3 Therapure Biopharma Chemotherapy Induced Anemia Introduction
13.8.4 Therapure Biopharma Revenue in Chemotherapy Induced Anemia Business (2015-2020)
13.8.5 Therapure Biopharma Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Chemotherapy Induced Anemia Key Market Segments
Table 2. Key Players Covered: Ranking by Chemotherapy Induced Anemia Revenue
Table 3. Ranking of Global Top Chemotherapy Induced Anemia Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Chemotherapy Induced Anemia Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Mild Anemia
Table 6. Key Players of Moderate Anemia
Table 7. Key Players of Severe Anemia
Table 8. Key Players of Life-Threatening Anemia
Table 9. Global Chemotherapy Induced Anemia Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Chemotherapy Induced Anemia Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Chemotherapy Induced Anemia Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Chemotherapy Induced Anemia Market Share by Regions (2015-2020)
Table 13. Global Chemotherapy Induced Anemia Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Chemotherapy Induced Anemia Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Chemotherapy Induced Anemia Market Growth Strategy
Table 19. Main Points Interviewed from Key Chemotherapy Induced Anemia Players
Table 20. Global Chemotherapy Induced Anemia Revenue by Players (2015-2020) (Million US$)
Table 21. Global Chemotherapy Induced Anemia Market Share by Players (2015-2020)
Table 22. Global Top Chemotherapy Induced Anemia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotherapy Induced Anemia as of 2019)
Table 23. Global Chemotherapy Induced Anemia by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Chemotherapy Induced Anemia Product Solution and Service
Table 26. Date of Enter into Chemotherapy Induced Anemia Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Chemotherapy Induced Anemia Market Size by Type (2015-2020) (Million US$)
Table 29. Global Chemotherapy Induced Anemia Market Size Share by Type (2015-2020)
Table 30. Global Chemotherapy Induced Anemia Revenue Market Share by Type (2021-2026)
Table 31. Global Chemotherapy Induced Anemia Market Size Share by Application (2015-2020)
Table 32. Global Chemotherapy Induced Anemia Market Size by Application (2015-2020) (Million US$)
Table 33. Global Chemotherapy Induced Anemia Market Size Share by Application (2021-2026)
Table 34. North America Key Players Chemotherapy Induced Anemia Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Chemotherapy Induced Anemia Market Share (2019-2020)
Table 36. North America Chemotherapy Induced Anemia Market Size by Type (2015-2020) (Million US$)
Table 37. North America Chemotherapy Induced Anemia Market Share by Type (2015-2020)
Table 38. North America Chemotherapy Induced Anemia Market Size by Application (2015-2020) (Million US$)
Table 39. North America Chemotherapy Induced Anemia Market Share by Application (2015-2020)
Table 40. Europe Key Players Chemotherapy Induced Anemia Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Chemotherapy Induced Anemia Market Share (2019-2020)
Table 42. Europe Chemotherapy Induced Anemia Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Chemotherapy Induced Anemia Market Share by Type (2015-2020)
Table 44. Europe Chemotherapy Induced Anemia Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Chemotherapy Induced Anemia Market Share by Application (2015-2020)
Table 46. China Key Players Chemotherapy Induced Anemia Revenue (2019-2020) (Million US$)
Table 47. China Key Players Chemotherapy Induced Anemia Market Share (2019-2020)
Table 48. China Chemotherapy Induced Anemia Market Size by Type (2015-2020) (Million US$)
Table 49. China Chemotherapy Induced Anemia Market Share by Type (2015-2020)
Table 50. China Chemotherapy Induced Anemia Market Size by Application (2015-2020) (Million US$)
Table 51. China Chemotherapy Induced Anemia Market Share by Application (2015-2020)
Table 52. Japan Key Players Chemotherapy Induced Anemia Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Chemotherapy Induced Anemia Market Share (2019-2020)
Table 54. Japan Chemotherapy Induced Anemia Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Chemotherapy Induced Anemia Market Share by Type (2015-2020)
Table 56. Japan Chemotherapy Induced Anemia Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Chemotherapy Induced Anemia Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Chemotherapy Induced Anemia Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Chemotherapy Induced Anemia Market Share (2019-2020)
Table 60. Southeast Asia Chemotherapy Induced Anemia Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Chemotherapy Induced Anemia Market Share by Type (2015-2020)
Table 62. Southeast Asia Chemotherapy Induced Anemia Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Chemotherapy Induced Anemia Market Share by Application (2015-2020)
Table 64. India Key Players Chemotherapy Induced Anemia Revenue (2019-2020) (Million US$)
Table 65. India Key Players Chemotherapy Induced Anemia Market Share (2019-2020)
Table 66. India Chemotherapy Induced Anemia Market Size by Type (2015-2020) (Million US$)
Table 67. India Chemotherapy Induced Anemia Market Share by Type (2015-2020)
Table 68. India Chemotherapy Induced Anemia Market Size by Application (2015-2020) (Million US$)
Table 69. India Chemotherapy Induced Anemia Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Chemotherapy Induced Anemia Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Chemotherapy Induced Anemia Market Share (2019-2020)
Table 72. Central & South America Chemotherapy Induced Anemia Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Chemotherapy Induced Anemia Market Share by Type (2015-2020)
Table 74. Central & South America Chemotherapy Induced Anemia Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Chemotherapy Induced Anemia Market Share by Application (2015-2020)
Table 76. Dr. Reddy’s Laboratories Company Details
Table 77. Dr. Reddy’s Laboratories Business Overview
Table 78. Dr. Reddy’s Laboratories Product
Table 79. Dr. Reddy’s Laboratories Revenue in Chemotherapy Induced Anemia Business (2015-2020) (Million US$)
Table 80. Dr. Reddy’s Laboratories Recent Development
Table 81. Pfizer Company Details
Table 82. Pfizer Business Overview
Table 83. Pfizer Product
Table 84. Pfizer Revenue in Chemotherapy Induced Anemia Business (2015-2020) (Million US$)
Table 85. Pfizer Recent Development
Table 86. Panacea Biotec Company Details
Table 87. Panacea Biotec Business Overview
Table 88. Panacea Biotec Product
Table 89. Panacea Biotec Revenue in Chemotherapy Induced Anemia Business (2015-2020) (Million US$)
Table 90. Panacea Biotec Recent Development
Table 91. 3SBio Company Details
Table 92. 3SBio Business Overview
Table 93. 3SBio Product
Table 94. 3SBio Revenue in Chemotherapy Induced Anemia Business (2015-2020) (Million US$)
Table 95. 3SBio Recent Development
Table 96. SBI Pharmaceuticals Company Details
Table 97. SBI Pharmaceuticals Business Overview
Table 98. SBI Pharmaceuticals Product
Table 99. SBI Pharmaceuticals Revenue in Chemotherapy Induced Anemia Business (2015-2020) (Million US$)
Table 100. SBI Pharmaceuticals Recent Development
Table 101. Tolero Pharmaceuticals Company Details
Table 102. Tolero Pharmaceuticals Business Overview
Table 103. Tolero Pharmaceuticals Product
Table 104. Tolero Pharmaceuticals Revenue in Chemotherapy Induced Anemia Business (2015-2020) (Million US$)
Table 105. Tolero Pharmaceuticals Recent Development
Table 106. Vifor Pharma Company Details
Table 107. Vifor Pharma Business Overview
Table 108. Vifor Pharma Product
Table 109. Vifor Pharma Revenue in Chemotherapy Induced Anemia Business (2015-2020) (Million US$)
Table 110. Vifor Pharma Recent Development
Table 111. Therapure Biopharma Business Overview
Table 112. Therapure Biopharma Product
Table 113. Therapure Biopharma Company Details
Table 114. Therapure Biopharma Revenue in Chemotherapy Induced Anemia Business (2015-2020) (Million US$)
Table 115. Therapure Biopharma Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chemotherapy Induced Anemia Market Share by Type: 2020 VS 2026
Figure 2. Mild Anemia Features
Figure 3. Moderate Anemia Features
Figure 4. Severe Anemia Features
Figure 5. Life-Threatening Anemia Features
Figure 6. Global Chemotherapy Induced Anemia Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Multispecialty Clinics Case Studies
Figure 10. Cancer Research Centers Case Studies
Figure 11. Cancer Rehabilitation Centers Case Studies
Figure 12. Chemotherapy Induced Anemia Report Years Considered
Figure 13. Global Chemotherapy Induced Anemia Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Chemotherapy Induced Anemia Market Share by Regions: 2020 VS 2026
Figure 15. Global Chemotherapy Induced Anemia Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Chemotherapy Induced Anemia Market Share by Players in 2019
Figure 18. Global Top Chemotherapy Induced Anemia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotherapy Induced Anemia as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Chemotherapy Induced Anemia Revenue in 2019
Figure 20. North America Chemotherapy Induced Anemia Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Chemotherapy Induced Anemia Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Chemotherapy Induced Anemia Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Chemotherapy Induced Anemia Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Chemotherapy Induced Anemia Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Chemotherapy Induced Anemia Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Chemotherapy Induced Anemia Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed

以下、関連資料のご紹介

化学療法誘発性貧血治療薬の世界市場（～2026年）

Global Chemotherapy Induced Anemia Drug Market Insights and Forecast to 2026
MRC2-11QY00176 2020年11月20日 110Pages
当調査資料は化学療法誘発性貧血治療薬のグローバル市場について調査・分析したレポートです。種類別（エポエチンゼータバイオシミラー、鉄カルボキシマルトース、ペグ化エリスロポエチン、その他）市場規模、用途別（クリニック、病院、在宅医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イ...

化学療法誘発性悪心・嘔吐（CINV）の世界市場（～2026年）

Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, Status and Forecast 2020-2026
MRC2-11QY11345 2020年11月25日 92Pages
当調査資料は化学療法誘発性悪心・嘔吐（CINV）のグローバル市場について調査・分析したレポートです。種類別（CINV、PONV）市場規模、用途別（病院、外来手術センター、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、...

化学療法薬誘発性肢端紅斑（手足症候群）治療の世界市場（～2026年）

Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11343 2020年11月25日 92Pages
当調査資料は化学療法薬誘発性肢端紅斑（手足症候群）治療のグローバル市場について調査・分析したレポートです。種類別（鎮痛剤、抗炎症剤・抗浮腫剤、抗ヒスタミン剤、NSAID、経口/局所グルココルチコイド、ピリドキシン（ビタミンB6）、その他）市場規模、用途別（薬局・ドラッグストア、病院薬局、オンラインド...

化学療法好中球減少症治療の世界市場（～2026年）

Global Chemotherapy-Induced Neutropenia Treatment Market Insights and Forecast to 2026
MRC2-11QY00179 2020年11月20日 115Pages
当調査資料は化学療法好中球減少症治療のグローバル市場について調査・分析したレポートです。種類別（抗生物質療法、コロニー刺激因子療法、顆粒球輸血、脾臓摘出術、その他）市場規模、用途別（病院、外来外科センター、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イ...

化学療法誘発性悪心・嘔吐（CINV）治療薬の世界市場（～2026年）

Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Insights and Forecast to 2026
MRC2-11QY00177 2020年11月20日 112Pages
当調査資料は化学療法誘発性悪心・嘔吐（CINV）治療薬のグローバル市場について調査・分析したレポートです。種類別（Aloxi、Zofran Generic、Kytril Generic、Emend、Akynzeo、SUSTOL、Rolapitant）市場規模、用途別（急性CINV、遅延CINV）市場...

化学療法誘発性好中球減少症治療薬の世界市場（～2026年）

Global Chemotherapy Induced Neutropenia Drug Market Insights and Forecast to 2026
MRC2-11QY00178 2020年11月20日 188Pages
当調査資料は化学療法誘発性好中球減少症治療薬のグローバル市場について調査・分析したレポートです。種類別（F-627、BBT-018、フィルグラスチム、GW-003、NLA-101、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギ...

貧血治療薬の世界市場（～2026年）

Global Anemia Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY10841 2020年11月25日 98Pages
当調査資料は貧血治療薬のグローバル市場について調査・分析したレポートです。種類別（鉄欠乏性貧血、鎌状赤血球貧血、悪性貧血、溶血性貧血）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、...

自己マトリックス誘導軟骨形成（AMIC）の世界市場（～2026年）

Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size, Status and Forecast 2020-2026
MRC2-11QY10932 2020年11月25日 95Pages
当調査資料は自己マトリックス誘導軟骨形成（AMIC）のグローバル市場について調査・分析したレポートです。種類別（ヒアルロン酸、コラーゲン、ポリエチレングリコール（PEG）、ポリ乳酸-co-グリコール酸（PGLA）、その他）市場規模、用途別（膝軟骨修復、股関節軟骨修復、肘軟骨修復、その他）市場規模、地...

鎌状赤血球貧血治療薬の世界市場（～2026年）

Global Sickle-cell Anemia Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04606 2020年11月20日 92Pages
当調査資料は鎌状赤血球貧血治療薬のグローバル市場について調査・分析したレポートです。種類別（輸血、薬物療法、骨髄移植）市場規模、用途別（子供、大人）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、...

オピオイド誘発性便秘（OIC）治療の世界市場（～2026年）

Global Opioid-Induced Constipation (OIC) Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04062 2020年11月20日 99Pages
当調査資料はオピオイド誘発性便秘（OIC）治療のグローバル市場について調査・分析したレポートです。種類別（経口、非経口（皮下注射））市場規模、用途別（ドラッグストア、独立型薬局、病院薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中...

化学療法誘発性貧血治療薬の世界市場（～2026年） Market Analysis and Insights: Global Chemotherapy Induced Anemia Drug Market The global Chemotherapy Induced Anemia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Chemotherapy Induced Anemia Drug Scope and Market…
貧血治療薬の世界市場（～2026年） Anemia is a disease in which the blood does not carry the optimal amount of oxygen due to red blood cell count or a severe reduction, in our report, it studies iron deficiency anemia, sickle cell anemia, pernicious anemia, hemolytic anemia. The iron deficiency anemia market segment accounted for the…
貧血・ビタミン検査の世界市場（～2026年） Anemia is a clinical condition where the human body does not have enough Red Blood Cells (RBC) or Haemoglobin or both which are paramount important to functioning of the human being. Haemoglobin is a part of RBC that carries oxygen to the various body tissue. If a person has less number of RBC or lo…
鎌状赤血球貧血治療薬の世界市場（～2026年） Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…
ファンコニ貧血治療薬の世界市場（～2026年） Market Analysis and Insights: Global Fanconi Anemia Drug Market The global Fanconi Anemia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Fanconi Anemia Drug Scope and Market Size Fanconi Anemia Drug market is seg…